| Lacosamide |
EU/1/08/470/005 |
VIMPAT, Film coated tablet, 100, mg, Pack: 56 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
119.91 |
23.98 |
143.89 |
4% |
4.8 |
124.71 |
24.94 |
149.65 |
16% |
19.19 |
143.9 |
28.78 |
172.68 |
|
НСР-8226/22.02.2016; НСР-10759/27.10.2016 |
11.11.2016 |
02.12.2016 |
Неактивен |
3397 |
| Lacosamide |
EU/1/08/470/011 |
VIMPAT, Film coated tablet, 200, mg, Pack: 56 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
240.02 |
48 |
288.02 |
4% |
9.6 |
249.62 |
49.92 |
299.54 |
16% |
25 |
274.62 |
54.92 |
329.54 |
|
НСР-8224/22.02.2016 |
09.03.2016 |
09.03.2016 |
Неактивен |
3399 |
| Lacosamide |
EU/1/08/470/008 |
VIMPAT, Film coated tablet, 150, mg, Pack: 56 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
179.92 |
35.98 |
215.9 |
4% |
7.2 |
187.12 |
37.42 |
224.54 |
16% |
25 |
212.12 |
42.42 |
254.54 |
|
НСР-8225/22.02.2016 |
09.03.2016 |
09.03.2016 |
Неактивен |
3398 |
| Lacosamide |
EU/1/08/470/005 |
VIMPAT, Film coated tablet, 100, mg, Pack: 56 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
120.09 |
24.02 |
144.11 |
4% |
4.8 |
124.89 |
24.98 |
149.87 |
16% |
19.21 |
144.1 |
28.82 |
172.92 |
|
НСР-8226/22.02.2016 |
09.03.2016 |
09.03.2016 |
Неактивен |
3397 |
| Lacosamide |
EU/1/08/470/008 |
VIMPAT, Film coated tablet, 150, mg, Pack: 56 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
182.3 |
36.46 |
218.76 |
4% |
7.29 |
189.59 |
37.92 |
227.51 |
16% |
25 |
214.59 |
42.92 |
257.51 |
промяна на обстоятелства НСР-8286/26.02.2016 |
НСР-5145/27.11.2014 |
11.12.2014 |
11.12.2014 |
Неактивен |
3398 |
| Lacosamide |
EU/1/08/470/011 |
VIMPAT, Film coated tablet, 200, mg, Pack: 56 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
243.07 |
48.61 |
291.68 |
4% |
9.72 |
252.79 |
50.56 |
303.35 |
16% |
25 |
277.79 |
55.56 |
333.35 |
промяна на обстоятелства НСР-8285/26.02.2016 |
НСР-5146/27.11.2014 |
11.12.2014 |
11.12.2014 |
Неактивен |
3399 |
| Lacosamide |
EU/1/08/470/005 |
VIMPAT, Film coated tablet, 100, mg, Pack: 56 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
121.57 |
24.31 |
145.88 |
4% |
4.86 |
126.43 |
25.29 |
151.72 |
16% |
19.45 |
145.88 |
29.18 |
175.06 |
промяна на обстоятелства НСР-8259/26.02.2016 |
НСР-5144/27.11.2014 |
11.12.2014 |
11.12.2014 |
Неактивен |
3397 |
| Lacosamide |
EU/1/08/470/011 |
VIMPAT, Film coated tablet, 200, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Belgium |
256.47 |
51.29 |
307.76 |
4% |
10 |
266.47 |
53.29 |
319.76 |
16% |
25 |
291.47 |
58.29 |
349.76 |
|
НСР-3083/21.03.2014 |
08.04.2014 |
08.04.2014 |
Неактивен |
3399 |
| Lacosamide |
EU/1/08/470/005 |
VIMPAT, Film coated tablet, 100, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Belgium |
128.28 |
25.66 |
153.94 |
4% |
5.13 |
133.41 |
26.68 |
160.09 |
16% |
20.52 |
153.93 |
30.79 |
184.72 |
|
НСР-3081/21.03.2014 |
08.04.2014 |
08.04.2014 |
Неактивен |
3397 |
| Lacosamide |
EU/1/08/470/008 |
VIMPAT, Film coated tablet, 150, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Belgium |
192.36 |
38.47 |
230.83 |
4% |
7.69 |
200.05 |
40.01 |
240.06 |
16% |
25 |
225.05 |
45.01 |
270.06 |
|
НСР-3082/21.03.2014 |
08.04.2014 |
08.04.2014 |
Неактивен |
3398 |
| Lacosamide |
EU/1/08/470/011 |
VIMPAT, Film coated tablet, 200, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
266.68 |
53.34 |
320.02 |
4% |
10 |
276.68 |
55.34 |
332.02 |
16% |
25 |
301.68 |
60.34 |
362.02 |
|
КЦРР-780/15.06.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3399 |
| Lacosamide |
EU/1/08/470/005 |
VIMPAT, Film coated tablet, 100, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
133.33 |
26.67 |
160 |
4% |
5.33 |
138.66 |
27.73 |
166.39 |
16% |
21.33 |
159.99 |
32 |
191.99 |
|
КЦРР-780/15.06.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3397 |
| Lacosamide |
EU/1/08/470/008 |
VIMPAT, Film coated tablet, 150, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
200 |
40 |
240 |
4% |
8 |
208 |
41.6 |
249.6 |
16% |
25 |
233 |
46.6 |
279.6 |
|
КЦРР-780/15.06.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3398 |
| Lacosamide |
EU/1/08/470/011 |
VIMPAT, Film coated tablet, 200, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
290.5 |
58.1 |
348.6 |
4% |
10 |
300.5 |
60.1 |
360.6 |
16% |
25 |
325.5 |
65.1 |
390.6 |
|
КЦ-2060/14.03.2011 |
29.03.2011 |
29.03.2011 |
Неактивен |
3399 |
| Lacosamide |
EU/1/08/470/008 |
VIMPAT, Film coated tablet, 150, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
220.17 |
44.03 |
264.2 |
4% |
8.81 |
228.98 |
45.8 |
274.78 |
16% |
25 |
253.98 |
50.8 |
304.78 |
|
КЦ-2059/14.03.2011 |
29.03.2011 |
29.03.2011 |
Неактивен |
3398 |
| Lacosamide |
EU/1/08/470/005 |
VIMPAT, Film coated tablet, 100, mg, Pack: 56 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
146.75 |
29.35 |
176.1 |
4% |
5.87 |
152.62 |
30.52 |
183.14 |
16% |
23.48 |
176.1 |
35.22 |
211.32 |
|
КЦ-2062/14.03.2011 |
29.03.2011 |
29.03.2011 |
Неактивен |
3397 |
| Lacosamide |
EU/1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
14.73 |
2.95 |
17.68 |
6% |
0.88 |
15.61 |
3.12 |
18.73 |
18% |
2.65 |
18.26 |
3.65 |
21.91 |
промяна на обстоятелства НСР-8276/26.02.2016 |
НСР-6904/06.08.2015.; НСР-10687/21.10.2016; НСР-17736/17.01.2019 |
01.02.2019 |
02.02.2019 |
Активен |
3396 |
| Lacosamide |
EU/1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
15.16 |
3.03 |
18.19 |
6% |
0.91 |
16.07 |
3.21 |
19.28 |
18% |
2.73 |
18.8 |
3.76 |
22.56 |
промяна на обстоятелства НСР-8276/26.02.2016 |
НСР-6904/06.08.2015.; НСР-10687/21.10.2016 |
08.11.2016 |
02.12.2016 |
Неактивен |
3396 |
| Lacosamide |
EU/1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
AESICA Pharmaceuticals GmbH, Germany; UCB Pharma SA, Belgium |
15.2 |
3.04 |
18.24 |
6% |
0.91 |
16.11 |
3.22 |
19.33 |
18% |
2.74 |
18.85 |
3.77 |
22.62 |
промяна на обстоятелства НСР-8276/26.02.2016 |
НСР-6904/06.08.2015. |
21.08.2015 |
21.08.2015 |
Неактивен |
3396 |
| Lacosamide |
EU1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
15.82 |
3.16 |
18.98 |
6% |
0.95 |
16.77 |
3.35 |
20.12 |
18% |
2.85 |
19.62 |
3.92 |
23.54 |
|
НСР-5136/27.11.2014 |
11.12.2014 |
11.12.2014 |
Неактивен |
3396 |
| Lacosamide |
EU1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
16.02 |
3.2 |
19.22 |
6% |
0.96 |
16.98 |
3.4 |
20.38 |
18% |
2.88 |
19.86 |
3.97 |
23.83 |
|
НСР-3080/21.03.2014 |
08.04.2014 |
08.04.2014 |
Неактивен |
3396 |
| Lacosamide |
EU1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
16.66 |
3.33 |
19.99 |
6% |
1 |
17.66 |
3.53 |
21.19 |
18% |
3 |
20.66 |
4.13 |
24.79 |
|
КЦРР-780/15.06.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3396 |
| Lacosamide |
EU1/08/470/001 |
VIMPAT, Film coated tablet, 50, mg, Pack: 14 |
UCB Pharma SA, Белгия |
UCB Pharma GmbH, Germany |
19.03 |
3.81 |
22.84 |
6% |
1.14 |
20.17 |
4.03 |
24.2 |
18% |
3.43 |
23.6 |
4.72 |
28.32 |
|
КЦ-2056/14.03.2011 |
29.03.2011 |
29.03.2011 |
Неактивен |
3396 |
| Vinblastine |
II-9569/18.08.2004 |
Vinblastine Teva, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Тева Фармасютикълс България ЕООД, България |
Pharmachemie BV, The Netherlands |
7.22 |
1.44 |
8.66 |
7% |
0.51 |
7.73 |
1.55 |
9.28 |
20% |
1.44 |
9.17 |
1.83 |
11 |
цената се заличава HCР-149/12.06.2013 |
КЦРР-2508/06.03.2013 |
21.03.2013 |
21.03.2013 |
Заличен |
1702 |
| Vinblastine |
II-9569/18.08.2004 |
Vinblastine Teva, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Тева Фармасютикълс България ЕООД, България |
Pharmachemie BV, The Netherlands; |
13.81 |
2.76 |
16.57 |
6% |
0.83 |
14.64 |
2.93 |
17.57 |
18% |
2.49 |
17.13 |
3.43 |
20.56 |
|
КЦ-833/23.04.2009 |
02.06.2009 |
02.06.2009 |
Неактивен |
1702 |